Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-25-000051
Filing Date
2025-05-02
Accepted
2025-05-02 12:33:47
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20250331.htm   iXBRL 10-Q 1270343
2 EX-31.1 bmrn-exx311xq12025.htm EX-31.1 9224
3 EX-31.2 bmrn-exx312xq12025.htm EX-31.2 9237
4 EX-32.1 bmrn-exx321xq12025.htm EX-32.1 5127
  Complete submission text file 0001048477-25-000051.txt   6511273

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20250331.xsd EX-101.SCH 41357
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20250331_cal.xml EX-101.CAL 72994
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20250331_def.xml EX-101.DEF 197456
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20250331_lab.xml EX-101.LAB 548329
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20250331_pre.xml EX-101.PRE 380235
74 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20250331_htm.xml XML 940041
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 25906752
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)